Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety, tolerability and preliminary efficacy data for FP-1201 in acute lung injury and acute respiratory distress syndrome f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• FP-1201

Snippet

Sponsor: Faron Pharmaceuticals Ltd | Conditions: Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-05-27